EUnetHTA Joint Action 2 3-year Work plan (2013)
The EUnetHTA Joint Action 2 3-Year Work Plan lays out details and timelines of the activities planned in each of the eight Work Packages of EUnetHTA JA2 and guides the work of EUnetHTA throughout 2012-2015. The EUnetHTA Executive Committee monitors the implementation of the Work Plan and discusses if any prospective amendments need to be […]
EMA-EUnetHTA press release on joint 3-year work plan
EMA-EUnetHTA press release on 3-year work plan
EMA-EUnetHTA 3-year Work Plan
This document is the 3-year work plan between the European Medicines Agency (EMA) and EUnetHTA. EMA-EUnetHTA three year work plan – final version
1st pilot rapid assessment of WP5 JA2 Strand B on “Duodenal-jejunal bypass sleeve for the treatment of obesity with or without Type II Diabetes Mellitus”
The purpose of the assessment is to examine the effectiveness and safety of the duodenal-jejunal bypass sleeve/EndoBarrier® in in adults aged 18 years or older with grade II or III obesity (with comorbidities) and/or type 2 diabetes mellitus (+ obesity ≥ grade I) who are not adequately controlled with medication (oral and/or insulin) and lifestyle […]
EMA-EUnetHTA meeting Summary Report November 2012
This is the summary report from the EMA-EUnetHTA meeting You can find the presentations from the meeting here EMA-EUnetHTA meeting Summary Report
Comments from PC of Draft Background Review on REA of Pharmaceuticals
This document is the comments provided during public consultation of Draft Background Review on Relative Effectiveness Assessment of Pharmaceuticals, carried out by the WP5 in JA1. This document is part of the JA1 Final Technical Report as Deliverable “D3-1 WP5 _1b_Comments public consultation background review REA WP5 20110708” NOTE: For the full Technical Report, please follow […]
